Francis Poulin
Head of Analytical Development Biologics Late Stage Takeda Pharmaceutical
Seminars
Wednesday 29th April 2026
Panel Discussion: Building a Fully Connected ADC Enterprise by Leveraging AI, Data, & Automation For End-to-End Development
5:00 pm
Moving beyond solving individual transfer issues to envision a future state of fully integrated development, powered by AI and automation. This panel will debate the cultural, technical, and regulatory roadblocks to achieving the transformative impact it would have on speed, cost, and quality.
Join a strategic discussion on building the agile ADC development organization of the future by:
- Envisioning how AI platforms analyze development data to automatically recommend optimal process parameters, analytical methods, and specifications, changing the role of scientists
- Exploring digital replica of the ADC process to virtually simulate the impact of changes, predict outcomes, and eliminate failed tech transfers
- Debating the organizational and cultural changes required to break down walls between process, analytical, and regulatory functions, enabling a truly agile and data-driven development lifecycle
Wednesday 29th April 2026
Leveraging Platform Analytical Methods to De-Risk Tech Transfer, Accelerate Timelines, & Ensure Global Supply Chain Flexibility for ADCs
4:00 pm
- Establish and deploy a robust platform of core analytical method to standardize procedures and reduce the need for method re-development, accelerating the transfer of analytics to new internal and external manufacturing sites
- Co-develop unambiguous method instructions with QC and CMO partners to eliminate variability introduced by differences in interpretation or execution, ensuring robust assay performance
- Design the analytical control strategy around a pre-qualified platform from the outset to build flexibility and resilience into the supply chain, enabling faster and more robust tech transfers for global product roll-outs